Mesoblast is a global leader in developing allogeneic cellular medicines for inflammatory diseases. With a focus on serious and life-threatening conditions, Mesoblast utilizes its proprietary mesenchymal lineage cell technology platform to create innovative treatments.

Mesoblast Inc. VP, Clinical Development. February 2011 - 2013. New York, New York. Alexion Pharmaceuticals, profile picture · Alexion Pharmaceuticals.

Mesoblast Limited (ASX:MSB; Nasdaq:MESO) is a global leader in developing allogeneic cellular medicines for inflammatory diseases.

Mesoblast (ASX:MSB; Nasdaq:MESO) is developing and commercializing allogeneic cellular medicines to treat serious and life-threatening inflammatory diseases ...

Mesoblast

Find contacts at this company